Lisa G. Suter

Lisa G. Suter

Auto-generated profile, based on publicly available information

Lisa G. Suter

Center for Outcomes Research and Evaluation, Yale New Haven Health Services Corporation, New Haven, Connecticut

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 March 2016 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
BDBhushan R. Deshpande
Bhushan R. Deshpande
JKJeffrey N. Katz
Jeffrey N. Katz
DSDaniel H. Solomon
Daniel H. Solomon
EYEdward H. Yelin
Edward H. Yelin
DHDavid Hunter
David Hunter
ELElena Losina
Elena Losina
Objective: The prevalence of symptomatic knee osteoarthritis (OA) has been increasing over the past several decades in the US, concurrent with an aging population and the growing obesity epidemic. We quantify the impact of these factors on the number of persons with symptomatic knee OA in the early decades of the 21st century.Methods: We calculated the prevalence of clinically diagnosed symptomatic knee OA from the National Health Interview Survey 2007–2008 and derived the proportion with advanced disease (defined as Kellgren/Lawrence grade 3 or 4) using the Osteoarthritis Policy Model, a validated simulation model of knee OA. Incorporating contemporary obesity rates and population estimates, we calculated the number of persons living with symptomatic knee OA.Results: We estimate that approximately 14 million persons had symptomatic knee OA, with advanced OA comprising more than half of those cases. This includes more than 3 million persons of racial/ethnic minorities (African American, Hispanic, and other). Adults younger than 45 years of age represented nearly 2 million cases of symptomatic knee OA and individuals between 45 and 65 years of age comprised 6 million more cases.Conclusion: More than half of all persons with symptomatic knee OA are younger than 65 years of age. As many of these younger persons will live for 3 decades or more, there is substantially more time for greater disability to occur, and policymakers should anticipate health care utilization for knee OA to increase in the upcoming decades. These data emphasize the need for the deployment of innovative prevention and treatment strategies for knee OA, especially among younger persons.

7 April 2005 in Arthritis & Rheumatism
Verified
Journal Article
Open access
PDF file
LSLisa G. Suter
Lisa G. Suter
JMJoanne Murabito, Murabito
Joanne Murabito, Murabito
DFDavid T. Felson
David T. Felson
LFLiana Fraenkel
Liana Fraenkel
Objective: Raynaud's phenomenon (RP) is a common disorder, yet its incidence and natural history are unknown. Our objective was to determine the incidence and natural history of RP not associated with a connective tissue disease in a large, community‐based population.Methods: Using serial examinations of the Framingham Heart Study offspring cohort, we collected data regarding RP symptoms for 717 women and 641 men over a 7‐year period. We used validated criteria for RP classification and categorized participants as having incident, persistent, or remitted RP. We performed sex‐specific analyses of RP status by age, body mass index, vibratory tool use, season of examination, state of residence, use of antihypertensive medications, and smoking status.Results: The mean ± SD age of participants was 53.5 ± 10 years. The incidence of RP was 2.2% in women (n = 14) and 1.5% in men (n = 9). Of the 78 women and 50 men who had RP at baseline, 36% of women (n = 28) and 36% of men (n = 18) had persistent RP. RP remitted in 64% of women (n = 50) and 64% of men (n = 32), with 41 women and 25 men meeting no or only 1 RP criterion at followup. RP episodes were infrequent and rarely interfered with daily activities.Conclusion: This is the first prospective study to determine the incidence and natural history of RP in a community‐based cohort. Our data demonstrate that RP not associated with a connective tissue disease is frequently a transient phenomenon and rarely interferes with daily activities.

14 May 2014 in Journal of General Internal Medicine
Verified
Journal Article
Open access
PDF file
LSLisa G. Suter
Lisa G. Suter
SLShu-Xia Li
Shu-Xia Li
JGJacqueline N. Grady
Jacqueline N. Grady
ZLZhenqiu Lin
Zhenqiu Lin
YWYongfei Wang
Yongfei Wang
SBSusannah M. Bernheim
Susannah M. Bernheim
BACKGROUND The Centers for Medicare & Medicaid Services publicly reports risk-standardized mortality rates (RSMRs) within 30-days of admission and, in 2013, risk-standardized unplanned readmission rates (RSRRs) within 30-days of discharge for patients hospitalized with acute myocardial infarction (AMI), heart failure (HF), and pneumonia. Current publicly reported data do not focus on variation in national results or annual changes. OBJECTIVE Describe U.S. hospital performance on AMI, HF, and pneumonia mortality and updated readmission measures to provide perspective on national performance variation. DESIGN To identify recent changes and variation in national hospital-level mortality and readmission for AMI, HF, and pneumonia, we performed cross-sectional panel analyses of national hospital performance on publicly reported measures. PARTICIPANTS Fee-for-service Medicare and Veterans Health Administration beneficiaries, 65 years or older, hospitalized with principal discharge diagnoses of AMI, HF, or pneumonia between July 2009 and June 2012. RSMRs/RSRRs were calculated using hierarchical logistic models risk-adjusted for age, sex, comorbidities, and patients’ clustering among hospitals. Results Median (range) RSMRs for AMI, HF, and pneumonia were 15.1% (9.4–21.0%), 11.3% (6.4–17.9%), and 11.4% (6.5–24.5%), respectively. Median (range) RSRRs for AMI, HF, and pneumonia were 18.2% (14.4–24.3%), 22.9% (17.1–30.7%), and 17.5% (13.6–24.0%), respectively. Median RSMRs declined for AMI (15.5% in 2009–2010, 15.4% in 2010–2011, 14.7% in 2011–2012) and remained similar for HF (11.5% in 2009–2010, 11.9% in 2010–2011, 11.7% in 2011–2012) and pneumonia (11.8% in 2009–2010, 11.9% in 2010–2011, 11.6% in 2011–2012). Median hospital-level RSRRs declined: AMI (18.5% in 2009–2010, 18.5% in 2010–2011, 17.7% in 2011–2012), HF (23.3% in 2009–2010, 23.1% in 2010–2011, 22.5% in 2011–2012), and pneumonia (17.7% in 2009–2010, 17.6% in 2010–2011, 17.3% in 2011–2012). Conclusions We report the first national unplanned readmission results demonstrating declining rates for all three conditions between 2009–2012. Simultaneously, AMI mortality continued to decline, pneumonia mortality was stable, and HF mortality experienced a small increase.


1 May 2013 in Osteoarthritis and Cartilage
Verified
Journal Article
Closed access
ELE. Losina
E. Losina
MDM.E. Daigle
M.E. Daigle
LSL.G. Suter
L.G. Suter
DHDavid Hunter
David Hunter
DSD.H. Solomon
D.H. Solomon
JKJ.N. Katz
J.N. Katz

31 March 2006 in Arthritis Care & Research
Verified
Journal Article
Open access
PDF file
LSLisa G. Suter
Lisa G. Suter
LFLiana Fraenkel
Liana Fraenkel
EHEric S. Holmboe
Eric S. Holmboe
Objective: Rheumatoid arthritis (RA) is a common, costly, and disabling disease. Early referral and treatment reduce long‐term joint damage and improve functional outcomes. Despite efforts to improve referral, half of patients with RA are not referred in a timely manner. Our objective was to explore the factors influencing the decision of a primary care physician (PCP) to refer or not refer a patient with suspected RA, and to identify modifiable factors influencing timely referral.Methods: Using qualitative methods and in‐depth, face‐to‐face interviews, we asked Connecticut PCPs to describe the last patient encounter where they suspected RA and the factors influencing referral and nonreferral. Participants represented a range of clinical experience, access to rheumatologists, and practice settings. Sample size was determined by thematic saturation. Transcripts were coded and analyzed using the constant comparative method of qualitative data analysis.Results: We interviewed 19 PCPs, 9 of whom were women. Our analysis identified clinical characteristics, patient preferences, access issues, clinical and administrative leadership, physician confidence and expectations, and interpersonal relationships as important domains influencing the referral decision. These domains interacted to impact timely referral and quality of care. Previously underappreciated factors, such as the magnitude of the effect of physician rapport, appeared to be critical in determining whether or not patients are promptly referred.Conclusion: Issues such as physician rapport, as well as clinical and system issues, influence referral for suspected RA. To improve referral for RA, clinical guidelines, medical education, and quality improvement efforts should address all domains influencing the referral decision.